We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

ELC Group in Early-Stage Development of Novel Influenza Vaccine

News   Jun 30, 2015

 
ELC Group in Early-Stage Development of Novel Influenza Vaccine
 
 
 

RELATED ARTICLES

Restricted Protein Diet Improves Immunotherapy Response in Mice

News

Restricting protein from a cancer patient's diet may enhance the response to immunotherapy.

READ MORE

Antibiotics Can Make Oral Infections Worse Rather than Better

News

The body’s own microbes are effective in maintaining immune cells and killing certain oral infections.

READ MORE

Cobra Biologics, GE Healthcare and Centre for Process Innovation Collaborate to Advance Gene Therapy

News

Innovate UK funded project supports development of scalable, cost effective production of regenerative medicines.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE